'Correction:' Serum transforming growth factor beta-1 (TGF-beta-1) levels in diabetic patients are not associated with pre-existent coronary artery disease

Schaan, Beatriz D.; Quadros, Alexandre S.; Sarmento-Leite, Rogério; De Lucca, Jr., Giuseppe; Bender, Alexandra; Bertoluci, Marcello
January 2007
Cardiovascular Diabetology;2007, Vol. 6, p19
Academic Journal
Background: The association between TGF- β1 levels and long-term major adverse cardiovascular events (MACE) in patients with coronary artery disease (CAD) is controversial. No study specifically addressed patients with CAD and diabetes mellitus (DM). The association between TGF- β1 levels and long-term major adverse cardiovascular events (MACE) in patients with coronary artery disease (CAD) is controversial. No study specifically addressed patients with CAD and diabetes mellitus (DM). Methods: Patients (n = 135, 30-80 years) referred for coronary angiography were submitted to clinical and laboratory evaluation, and the coronary angiograms were evaluated by two operators blinded to clinical characteristics. CAD was defined as the presence of a 70% stenosis in one major coronary artery, and DM was characterized as a fasting glycemia > 126 mg/dl or known diabetics (personal history of diabetes or previous use of anti-hyperglycemic drugs or insulin). Based on these criteria, study patients were classified into four groups: no DM and no CAD (controls, C n = 61), DM without CAD (D n = 23), CAD without DM (C-CAD n = 28), and CAD with DM (D-CAD n = 23). Baseline differences between the 4 groups were evaluated by the χ ² test for trend (categorical variables) and by ANOVA (continuous variables, post-hoc Tukey). Patients were then followed-up during two years for the occurrence of MACE (cardiac death, stroke, myocardial infarction or myocardial revascularization). The association of candidate variables with the occurrence of 2-year MACE was assessed by univariate analysis. Results: The mean age was 58.2 ± 0.9 years, and 51% were men. Patients with CAD had a higher mean age (p = 0.011) and a higher percentage were male (p = 0.040). There were no significant baseline differences between the 4 groups regarding hypertension, smoking status, blood pressure levels, lipid levels or inflammatory markers. TGF-β1 was similar between patients with or without CAD or DM (35.1 ×/÷ 1.3, 33.6 ×/÷ 1.6, 33.9 ×/÷ 1.4 and 31.8 ×/÷ 1.4 ng/ml in C, D, C-CAD and D-CAD, respectively, p = 0.547). In the 2-year follow-ip, independent predictors of 2-year MACE were age (p = 0.007), C-reactive protein (p = 0.048) and systolic blood pressure (p = 0.008), but not TGF-β1. Conclusion: Serum TGF-β1 was not associated with CAD or MACE occurrence in patients with or without DM.


Related Articles

  • Predictive value of coronary calcifications for future cardiac events in asymptomatic patients with diabetes mellitus: A prospective study in 716 patients over 8 years. Becker, Alexander; Leber, Alexander W.; Becker, Christoph; von Ziegler, Franz; Tittus, Janine; Schnoeder, Ines; Steinbeck, Gerhard; Knez, Andreas // BMC Cardiovascular Disorders;2008, Vol. 8, Special section p1 

    Background: To establish an efficient prophylaxis of coronary artery disease reliable risk stratification is crucial, especially in the high risk population of patients suffering from diabetes mellitus. This prospective study determined the predictive value of coronary calcifications for future...

  • Protective effect of ginsenoside Rb1 against myocardial ischemia/reperfusion injury in streptozotocin-induced diabetic rats. Wu, Yang; Xia, Zhong-yuan; Dou, Juan; Zhang, Li; Xu, Jin-jin; Zhao, Bo; Lei, Shaoqing; Liu, Hui-min // Molecular Biology Reports;Oct2011, Vol. 38 Issue 7, p4327 

    The objective of the current study is to investigate whether ginsenoside Rb1, a major pharmacological extract of ginseng that could attenuate myocardial ischemia reperfusion (MI/R) injury in non-diabetic myocardium, can attenuate MI/R injury in diabetes that are more vulnerable to ischemic...

  • Impact of the individual components of the metabolic syndrome and their different combinations on the prevalence of atherosclerotic vascular disease in type 2 diabetes: the Diabetes in Germany (DIG) study. Hanefeld, Markolf; Koehler, Carsta; Gallo, Silvina; Benke, Inge; Ott, Petra // Cardiovascular Diabetology;2007, Vol. 6, p13 

    Background: One of the major controversies surrounding the metabolic syndrome (MetS) in type 2 diabetes is whether its single components act synergistically as risk factors for atherosclerotic vascular disease (AVD). We aimed to answer this by evaluating the relationship, and its various...

  • Microalbuminuria in patients with previous myocardial infarction. Henareh, L.; Jogestrand, T.; Agewall, S. // Kidney International;Jan2006, Vol. 69 Issue 1, p178 

    Microalbuminuria (MA) is a cardiovascular risk factor. The aim of this study was to examine the relationship between MA and the intima–media complex of the carotid and brachial artery, endothelial function, glucose metabolism, haemostatic variables and cardiac hypertrophy in patients with...

  • Influence of admission plasma glucose level on short- and long-term prognosis in patients with ST-segment elevation myocardial infarction. Mladenović, Violeta; Zdravković, Vladimir; Jović, Marina; Vučić, Rada; Irić-Ćupić, Violeta; Rosić, Mirko // Vojnosanitetski Pregled: Military Medical & Pharmaceutical Journ;Apr2010, Vol. 67 Issue 4, p291 

    Background/Aim. Hyperglicemia is common in patients with ST-elevation myocardial infarction (STEMI) and is associated with high risk of mortality and morbidity. Relationship between admission plasma glucose (APG) levels and mortality in diabetic and nondiabetic patients with STEMI needs further...

  • Incidencia del infarto agudo de miocardio en la evolución de los pacientes en tratamiento con diálisis. Sánchez-Perales, Carmen; Vázquez-Ruiz de Castroviejo, Eduardo; Segura-Torres, Pilar; Borrego-Utiel, Francisco; José García-Cortés, M.; García-García, Francisco; Mar Biechy-Baldan, M.; Gil-Cunquero, José M.; Liébana-Cañada, Antonio // Nefrologia;2012, Vol. 32 Issue 5, p597 

    Background: Although the estimated frequency of coronary artery disease (CAD) in patients on dialysis is very high, there is considerable variation in the studies published to date regarding the rate of acute myocardial infarction (AMI) in these patients. Objective: To establish the incidence of...

  • The prognostic value of different glucose abnormalities in patients with acute myocardial infarction treated invasively. Mazurek, Michal; Kowalczyk, Jacek; Lenarczyk, Radoslaw; Zielinska, Teresa; Sedkowska, Agnieszka; Pruszkowska-Skrzep, Patrycja; Swiatkowski, Andrzej; Sredniawa, Beata; Kowalski, Oskar; Polonski, Lech; Strojek, Krzysztof; Kalarus, Zbigniew // Cardiovascular Diabetology;2012, Vol. 11 Issue 1, p78 

    Background: Diabetes (DM) deteriorates the prognosis in patients with coronary heart disease. However, the prognostic value of different glucose abnormalities (GA) other than DM in subjects with acute myocardial infarction (AMI) treated invasively remains unclear. Aims: To assess the incidence...

  • Type 2 Diabetes as a "Coronary Heart Disease Equivalent". Juutilainen, Auni; Lehto, Seppo; Rönnemaa, Tapani; Pyörälä, Kalevi; Laakso, Markku // Diabetes Care;Dec2005, Vol. 28 Issue 12, p2901 

    OBJECTIVE -- The purpose of this study was to investigate the hypothesis that coronary heart disease (CHD) mortality in diabetic subjects without prior evidence of CHD is equal t9 that in nondiabetic subjects with prior myocardial infarction or any prior evidence of CHD. RESEARCH DESIGN AND...

  • Antiplatelet Therapy Following Myocardial Infarction in Patients With Diabetes. Bhatt, Deepak L. // JAMA: Journal of the American Medical Association;9/5/2012, Vol. 308 Issue 9, p921 

    The author reflects on the ischemic events that are still common after such advancement in the field of patient with diabetes with myocardial infarction (Ml). He informs that the platelet reactivity is highlighted for this increased risk of the patients in this category. He further informs that...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics